Jadhav Priyanka, Lal Hingorani, Kshirsagar Nilima
University Department of Infectious Diseases and University Department of Interpathy Research and Technology, Maharashtra University of Health Sciences, K.E.M. Hospital, New Delhi, India.
Pharmanza Herbals Private Limited, New Delhi, India.
Pharmacogn Mag. 2014 Jan;10(Suppl 1):S86-91. doi: 10.4103/0973-1296.127352.
Despite of new vaccines, the threat of influenza infection persists. In addition, availability, cost, duration of protection rendered and effectiveness of vaccines additional to the need of effective drug therapy makes influenza a challenge, which the globe faces. Traditionally used herbs and their decoctions are used for ages to cure symptoms similar to influenza. Tulsi or Ocimum sanctum is one of these major herbs used for influenza-like disease treatment. We attempted to explore a new methodology for assessing phosphatidyl choline (PC)-complexed O. sanctum methanol extract in embryonated vaccine quality eggs model.
The PC-complexed O. sanctum methanol extract was prepared and standardized using High-Performance Liquid Chromatography (HPLC). (Data not provided here) Nine to 11 days embryonated eggs were inoculated with the virus and drug mixture and then harvested to perform a hemagglutination (HA) test on the allantoic fluid. The experiments were performed at three different concentrations of ursolic acid with various virus concentration and dose levels of drugs. The HA titer was calculated from all experiments and observed for any inhibition of virus.
In initial experiments, matrix method for drug and virus concentration was employed. It was observed that the drug exhibited some response for 3log EID50 (egg infective dose) in few samples at 1:2 HA titer, but no response was observed at 4log EID50. In subsequent experiment, all the virus titers from 7log EID50 to 2log EID50 demonstrated positive HA titer of 1:64. However, the drug failed to exhibit any significant inhibition at any level of demonstrable virus titer. At all the concentrations, O. sanctum extracts were found to be safe.
The embryonated egg model may be utilized further to screen other drugs, which possess direct inhibitory properties like neuraminidase inhibition, and O. sanctum does not inhibit the influenza virus in this model at the given concentration.
尽管有了新疫苗,流感感染的威胁依然存在。此外,疫苗的可获得性、成本、提供的保护持续时间和有效性,再加上有效药物治疗的需求,使得流感成为全球面临的一项挑战。传统使用的草药及其煎剂长期以来一直用于治疗与流感相似的症状。图尔西或神圣罗勒是用于治疗流感样疾病的这些主要草药之一。我们试图探索一种新方法,在鸡胚疫苗质量蛋模型中评估磷脂酰胆碱(PC)复合的神圣罗勒甲醇提取物。
制备PC复合的神圣罗勒甲醇提取物,并使用高效液相色谱法(HPLC)进行标准化。(此处未提供数据)将9至11日龄的鸡胚接种病毒和药物混合物,然后收获以对尿囊液进行血凝试验(HA)。实验在三种不同浓度的熊果酸以及不同病毒浓度和药物剂量水平下进行。从所有实验中计算HA滴度,并观察对病毒的任何抑制作用。
在最初的实验中,采用了药物和病毒浓度的矩阵法。观察到在1:2 HA滴度下,少数样品中的药物对3log EID50(鸡胚感染剂量)有一些反应,但在4log EID50时未观察到反应。在随后的实验中,所有从7log EID50到2log EID50的病毒滴度均显示出1:64的阳性HA滴度。然而,在任何可检测到的病毒滴度水平下,该药物均未表现出任何显著抑制作用。在所有浓度下,均发现神圣罗勒提取物是安全的。
鸡胚模型可进一步用于筛选其他具有直接抑制特性(如神经氨酸酶抑制)的药物,在该模型中,给定浓度下的神圣罗勒不会抑制流感病毒。